Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of “Moderate Buy” from Brokerages

Agilent Technologies, Inc. (NYSE:A) has been assigned a consensus rating of “Moderate Buy” from the fifteen brokerages that are presently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $148.6923.

Several research analysts have weighed in on the company. JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday. Evercore ISI increased their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday. Barclays increased their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday. Finally, Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research report on Wednesday. They set a “buy” rating and a $165.00 price objective on the stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of A. Capital A Wealth Management LLC increased its position in shares of Agilent Technologies by 10,600.0% in the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the period. Stone House Investment Management LLC bought a new position in shares of Agilent Technologies in the first quarter worth $30,000. Opal Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the first quarter worth $31,000. Ransom Advisory Ltd bought a new position in shares of Agilent Technologies in the first quarter worth $32,000. Finally, Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies in the second quarter worth $33,000.

Agilent Technologies Stock Down 2.5%

A stock opened at $136.62 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $38.73 billion, a PE ratio of 32.07, a PEG ratio of 4.57 and a beta of 1.26. Agilent Technologies has a 1-year low of $96.43 and a 1-year high of $153.84. The business’s 50 day simple moving average is $125.04 and its 200 day simple moving average is $117.05.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts anticipate that Agilent Technologies will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.